| Jessica Michelle Thoreen, APRN | |
|
60 Commercial St Ste 404, Concord, NH 03301-5096 | |
| (603) 228-1763 | |
| (603) 227-7539 |
| Full Name | Jessica Michelle Thoreen |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 60 Commercial St Ste 404, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801123922 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Michelle Thoreen, APRN 60 Commercial St Ste 404, Concord, NH 03301-5096 Ph: (603) 228-1763 | Jessica Michelle Thoreen, APRN 60 Commercial St Ste 404, Concord, NH 03301-5096 Ph: (603) 228-1763 |
News Archive
Inex Pharmaceuticals announced today that United States Food and Drug Administration (FDA) provided an action letter detailing that the anticancer drug Marqibo (vincristine sulfate liposomes injection) is "not approvable" under the FDA's accelerated approval regulations based on the phase 2 clinical trial data submitted.
The European R&D project BrainAble, led by Barcelona Digital, has just successfully ended by developing a prototype that allows patients with severe functional disability to be more active and independent.
Allos Therapeutics, Inc. today reported a new analysis of data from the Company's pivotal PROPEL trial of FOLOTYN™ (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is based on overall response rate. Clinical benefit such as improvement in progression free survival or overall survival has not been demonstrated.
Physicians and registered dietitians who are trained in a new communication method called motivational interviewing may be able to help families change lifestyle behaviors, according to a study by a pediatrician at Brenner Children's Hospital, part of Wake Forest University Baptist Medical Center.
AMAG Pharmaceuticals, Inc. today announced positive new data from the FIRST head-to-head trial comparing Feraheme (ferumoxytol) Injection for intravenous (IV) use to iron sucrose in patients with iron deficiency anemia and chronic kidney disease.
› Verified 7 days ago
Ms. Sandra Arleigh Dinning, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-6108 | |
Ardell Currier, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7140 Fax: 603-227-7187 | |
Judith Ann Ainsworth, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7000 | |
Ms. Jennifer L Mcfadden, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 239 Pleasant St, Concord, NH 03301 Phone: 603-224-6561 | |
Janie Ann Boyle, MS, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 18 Foundry St, Suite 201, Concord, NH 03301 Phone: 603-228-0071 Fax: 603-228-7014 | |
Sara Joan Joncas, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St., Concord, NH 03301 Phone: 603-228-7200 Fax: 603-227-7562 | |
Kim Ann Eldredge, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10 Ferry St Ste 313, Concord, NH 03301 Phone: 860-788-6404 |